# 4J Therapeutics Inc. — Form D

4J Therapeutics Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-12. The offering totals $10K, of which $10K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-09-12
- Form: D
- Accession: 0001943773-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10K
- Amount sold: $10K
- Investors: 4
- Date of first sale: 2022-08-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-458589

## Issuer

- Name: 4J Therapeutics Inc.
- CIK: 0001943773
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 965 CLARK WAY, PALO ALTO, CA, 94304
- Phone: 650-575-4107

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Menashe Elazar | Director | Palo Alto, CA |
| Jeffrey S Glenn | Director | Palo Alto, CA |
| Edward Pham | Director | Palo Alto, CA |
| Nancy Chang | Executive Officer | Houston, TX |
| Menashe Elazar | Executive Officer | Palo Alto, CA |
| Edward Pham | Executive Officer | Palo Alto, CA |

## More

- [CIK 1943773 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1943773&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001943773-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.